Cannabis oil for autism in children
No cannabis oil product is approved by the U.S. Food and Drug Administration to treat autism spectrum disorder. Pediatric groups advise against use outside research. Evidence comes from small trials, case reports, and parent surveys. Those designs cannot prove that cannabis oil improves autism symptoms.
What "cannabis oil" means
The term covers extracts with different cannabinoid profiles. A product may hold cannabidiol (CBD) as the main compound with trace tetrahydrocannabinol (THC). Another may hold THC as the main compound. Labels on some products do not match lab test results, so the actual dose of CBD and THC is often unknown.
What studies report
The most cited study enrolled 188 children in Israel. They received a CBD-rich extract with a 20:1 CBD to THC ratio for six months. Parents rated 30% of children as much improved, 53% as improved, and 17% as unchanged. The study had no placebo group. Parent ratings can reflect expectation.
Cannabis for Autism Side Effects: What to Watch For
A later randomized trial in the same program tested a CBD-rich extract against placebo. That trial did not confirm the open-label response. Systematic reviews conclude that the evidence is not enough to recommend cannabis for autism.
what cannabis strain is good for autism
Side effects reported
- Somnolence
- Decreased appetite
- Irritability
- Vomiting or diarrhea
- Elevated liver enzymes
THC can cause intoxication, dizziness, and anxiety. THC exposure during childhood may affect brain development. Data on long-term effects in children with autism are absent.
Drug interactions
CBD inhibits several CYP450 enzymes, including CYP3A4, CYP2C19, and CYP2C9. It raises blood levels of some antiseizure drugs, such as clobazam and valproate. The FDA label for the purified CBD drug Epidiolex requires liver enzyme monitoring. Similar monitoring applies to most CBD products used at high doses.
Legal status
The FDA has approved one cannabis-derived drug, Epidiolex (cannabidiol), for three seizure disorders: Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. Autism is not on that list. State medical cannabis programs differ. Some list autism as a qualifying condition. Others do not.
Questions for a clinician
- Is there a clinical trial my child can join?
- What CBD to THC ratio would you consider, if any?
- Which blood tests do you need before and during use?
- How will cannabis interact with my child's current drugs?
- What side effects should stop treatment?
Unknowns
No standard dose exists. No standard ratio exists. Long-term data on brain development, puberty, and behavior are absent. Most pediatric neurologists and the American Academy of Pediatrics advise against cannabis use in children outside research settings.